Patricia Smith Choban
Research Subjects
Patricia Smith Choban has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Louis Flancbaum
Department of Surgery, Ohio State University, Columbus 43210, USA
3 shared publications Benita Jackson
1 shared publicationBrandon Lu
Loyola University Medical Center
1 shared publicationD Scales
Department of Surgery, College of Medicine, The Ohio State University, Columbus 43210, USA
1 shared publicationD W Ziegler
1 shared publicationG A Wilson
1 shared publication
Latest Publications
- 1 August 2005
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 20 (4) , 480-487
Morbid Obesity and Nutrition Support: Is Bigger Different?
Morbid obesity (body mass index >40 kg/m2 or >35 kg/m2 in the presence of an severe‐obesity‐related comorbid disease) is increasing in frequency in the United States and worldwide. This population has a variety of medical and surgical disorders that result in hospitalizations. It is not unexpected to encounter these patients on the nutrition support service. The obesity comorbid diseases that may increase complications related to nutrition support are present in greater frequency and severity in the morbidly obese population than in the nonobese population. To reduce these potential complications, strategies of hypocaloric nutrition have been advocated for obese patients, and this study focuses specifically on the morbidly obese subset.
- 1 August 2005
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 20 (4) , 480-487
Morbid Obesity and Nutrition Support: Is Bigger Different?
Morbid obesity (body mass index >40 kg/m2 or >35 kg/m2 in the presence of an severe‐obesity‐related comorbid disease) is increasing in frequency in the United States and worldwide. This population has a variety of medical and surgical disorders that result in hospitalizations. It is not unexpected to encounter these patients on the nutrition support service. The obesity comorbid diseases that may increase complications related to nutrition support are present in greater frequency and severity in the morbidly obese population than in the nonobese population. To reduce these potential complications, strategies of hypocaloric nutrition have been advocated for obese patients, and this study focuses specifically on the morbidly obese subset.
- Open Access
- 1 February 2005
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 20 (1) , 1-2
Low‐Carbohydrate Diets: Mythical Phoenix or Grail Quest?
- 1 February 2005
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 20 (1) , 1-2
Open AccessLow‐Carbohydrate Diets: Mythical Phoenix or Grail Quest?
- Open Access
- 1 November 2002
- Published by Cleveland Clinic Journal of Medicine in Cleveland Clinic Journal of Medicine
- Vol. 69 (11) , 897-903
Bariatric surgery for morbid obesity: why, who, when, how, where, and then what?
Bariatric surgery is not a cure, but it can take weight off and keep it off, improve most obesity-related conditions, reduce the risk of premature death, and improve quality of life. Given the interest in the procedure, primary care physicians need to understand the risks and benefits to help patients determine if this therapy is a good option, and they need to know the health changes that may occur after surgery when following these patients.
- 1 November 2002
- Published by Cleveland Clinic Journal of Medicine in Cleveland Clinic Journal of Medicine
- Vol. 69 (11) , 897-903
Open AccessBariatric surgery for morbid obesity: why, who, when, how, where, and then what?
Bariatric surgery is not a cure, but it can take weight off and keep it off, improve most obesity-related conditions, reduce the risk of premature death, and improve quality of life. Given the interest in the procedure, primary care physicians need to understand the risks and benefits to help patients determine if this therapy is a good option, and they need to know the health changes that may occur after surgery when following these patients.
- 1 December 2000
- Published by Springer Nature in Obesity Surgery
- Vol. 10 (6) , 553-556
Insurance Decisions about Obesity Surgery: A New Type of Randomization?
Studies of obesity surgery are frequently criticized for lack of an appropriate non-operative control arm. Additionally, insurance approval for coverage of these procedures can be difficult to obtain by patients and caregivers. This retrospective study tested the hypothesis that the insurance preapproval process would yield well-matched operative and non-operative treatment groups which could simulate a randomization process. Of 466 patients deemed to be appropriate candidates for surgery, 58% ultimately received surgical therapy. Roux-en-Y gastric bypass (RYGBP) was performed on 244 patients who were compared with 187 patients who did not undergo surgery (NonOP). The groups were similar in gender (81% female), age (39 yr), and Body Mass Index (52 kg/m2). The percentage of African Americans in the NonOP group was greater. The distribution of comorbid conditions among the groups were similar. The insurance approval process results in a reasonable control group for parameters except race.
- 1 December 2000
- Published by Springer Nature in Obesity Surgery
- Vol. 10 (6) , 553-556
Insurance Decisions about Obesity Surgery: A New Type of Randomization?
Studies of obesity surgery are frequently criticized for lack of an appropriate non-operative control arm. Additionally, insurance approval for coverage of these procedures can be difficult to obtain by patients and caregivers. This retrospective study tested the hypothesis that the insurance preapproval process would yield well-matched operative and non-operative treatment groups which could simulate a randomization process. Of 466 patients deemed to be appropriate candidates for surgery, 58% ultimately received surgical therapy. Roux-en-Y gastric bypass (RYGBP) was performed on 244 patients who were compared with 187 patients who did not undergo surgery (NonOP). The groups were similar in gender (81% female), age (39 yr), and Body Mass Index (52 kg/m2). The percentage of African Americans in the NonOP group was greater. The distribution of comorbid conditions among the groups were similar. The insurance approval process results in a reasonable control group for parameters except race.
- 1 May 1998
- Vol. 64 (5) , 471-5
Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome.
The objective of this study was to review the incidence, risk factors, methods of diagnosis, and outcome of acute acalculous cholecystitis (AAC) and to identify the sensitivity and limitations of current radiographic modalities used to establish the diagnosis. Our study was a retrospective chart review in a tertiary-care university hospital. Over a 53-month period, 27 cases of AAC (17 males, 10 females; mean age 50 years; mean Acute Physiology and Chronic Health Evaluation II score, 17) were encountered. Of these, 14 (52%) occurred in critically ill patients and 17 (63%) in patients recovering from non-biliary tract operations. AAC occurred in 0.19 per cent of surgical intensive care unit admissions and accounted for 14 per cent (27 of 188) of all cases of acute cholecystitis. Presenting symptoms and laboratory values were nonspecific. Twenty patients had radiographic studies before surgery. Among the various radiological studies used for AAC, morphine cholescintigraphy had the highest sensitivity (9 of 10; 90%), followed by computed tomography (8 of 12; 67%) and ultrasonography (2 of 7; 29%). Ten of the 20 patients had more than one study done preoperatively. All 27 patients had an open cholecystectomy. AAC was associated with a high incidence of gangrene (17 of 27 cases; 63%), perforation (4 of 27; 15%), and abscess (1 of 27; 4%). The mortality rate was 41 per cent (11 of 27). We conclude that AAC is a rare, but potentially lethal, disease occurring in critically ill patients and those recovering from non-biliary tract operations. The clinical presentation is nonspecific, and significant delays in diagnosis result in a high incidence of gangrene, perforation, abscess, and death. To improve outcome, a high index of suspicion with early radiographic evaluation, often employing multiple studies, is necessary. An algorithm for the evaluation of patients for suspected AAC is proposed.
- 1 May 1998
- Vol. 64 (5) , 471-5
Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome.
The objective of this study was to review the incidence, risk factors, methods of diagnosis, and outcome of acute acalculous cholecystitis (AAC) and to identify the sensitivity and limitations of current radiographic modalities used to establish the diagnosis. Our study was a retrospective chart review in a tertiary-care university hospital. Over a 53-month period, 27 cases of AAC (17 males, 10 females; mean age 50 years; mean Acute Physiology and Chronic Health Evaluation II score, 17) were encountered. Of these, 14 (52%) occurred in critically ill patients and 17 (63%) in patients recovering from non-biliary tract operations. AAC occurred in 0.19 per cent of surgical intensive care unit admissions and accounted for 14 per cent (27 of 188) of all cases of acute cholecystitis. Presenting symptoms and laboratory values were nonspecific. Twenty patients had radiographic studies before surgery. Among the various radiological studies used for AAC, morphine cholescintigraphy had the highest sensitivity (9 of 10; 90%), followed by computed tomography (8 of 12; 67%) and ultrasonography (2 of 7; 29%). Ten of the 20 patients had more than one study done preoperatively. All 27 patients had an open cholecystectomy. AAC was associated with a high incidence of gangrene (17 of 27 cases; 63%), perforation (4 of 27; 15%), and abscess (1 of 27; 4%). The mortality rate was 41 per cent (11 of 27). We conclude that AAC is a rare, but potentially lethal, disease occurring in critically ill patients and those recovering from non-biliary tract operations. The clinical presentation is nonspecific, and significant delays in diagnosis result in a high incidence of gangrene, perforation, abscess, and death. To improve outcome, a high index of suspicion with early radiographic evaluation, often employing multiple studies, is necessary. An algorithm for the evaluation of patients for suspected AAC is proposed.
- Open Access
- 1 September 1997
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 66 (3) , 546-550
Hypoenergetic nutrition support in hospitalized obese patients: a simplified method for clinical application
Nutrition support in obese hospitalized patients is controversial, with some practitioners advocating restricted energy or hypoenergetic feedings when patients are being actively treated for another disease. To eliminate the need for indirect calorimetry, this randomized, double-blind, prospective study was undertaken to determine whether obese hospitalized patients given a hypoenergetic parenteral regimen administered to provide 2 g protein x kg ideal body wt (IBW)(-1) x d(-1), could achieve nitrogen balance comparable with that of control subjects given isonitrogenous normoenergetic formula. Thirty obese hospitalized patients with an average body mass index (BMI; in kg/m2) of 35 were randomly assigned to the hypoenergetic [energy (kJ):nitrogen (g) = 314:1; energy (kcal):nitrogen (g) = 75:1; n = 16] or control [energy (kJ):nitrogen (g) = 628:1; energy (kcal):nitrogen (g) = 150:1; n = 14] formulas. The initial formula volume administered provided 2 g protein x kg IBW(-1) x d(-1). Nitrogen balance was determined on day 0 and weekly. The total daily energy intake [per kg actual body weight (ABW)] was 57 +/- 12 kJ (hypoenergetic) compared with 94 +/- 21 kJ (control), P < 0.001, and the nonprotein energy intake was 36 +/- 10 kJ (hypoenergetic) compared with 73 +/- 17 kJ (control), P < 0.001. Protein intake was the same per ABW, 2.0 +/- 0.2 and 2.0 +/- 0.1 g kg IBW(-1) x d(-1), NS, for the hypoenergetic and control formulas, respectively. Mean net nitrogen balance was not significantly different between the groups, even after patients were subgrouped by illness, nor was the percentage of patients achieving positive nitrogen balance. Duration of treatment averaged 10.5 +/- 2.6 d. Weight change did not differ significantly between groups. These data indicate that patients receiving hypoenergetic feedings providing 2 g protein x kg IBW(-1) x d(-1) achieved nitrogen balance comparable with patients given conventional total parenteral nutrition regimens, even when critically ill.
- 1 September 1997
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 66 (3) , 546-550
Open AccessHypoenergetic nutrition support in hospitalized obese patients: a simplified method for clinical application
Nutrition support in obese hospitalized patients is controversial, with some practitioners advocating restricted energy or hypoenergetic feedings when patients are being actively treated for another disease. To eliminate the need for indirect calorimetry, this randomized, double-blind, prospective study was undertaken to determine whether obese hospitalized patients given a hypoenergetic parenteral regimen administered to provide 2 g protein x kg ideal body wt (IBW)(-1) x d(-1), could achieve nitrogen balance comparable with that of control subjects given isonitrogenous normoenergetic formula. Thirty obese hospitalized patients with an average body mass index (BMI; in kg/m2) of 35 were randomly assigned to the hypoenergetic [energy (kJ):nitrogen (g) = 314:1; energy (kcal):nitrogen (g) = 75:1; n = 16] or control [energy (kJ):nitrogen (g) = 628:1; energy (kcal):nitrogen (g) = 150:1; n = 14] formulas. The initial formula volume administered provided 2 g protein x kg IBW(-1) x d(-1). Nitrogen balance was determined on day 0 and weekly. The total daily energy intake [per kg actual body weight (ABW)] was 57 +/- 12 kJ (hypoenergetic) compared with 94 +/- 21 kJ (control), P < 0.001, and the nonprotein energy intake was 36 +/- 10 kJ (hypoenergetic) compared with 73 +/- 17 kJ (control), P < 0.001. Protein intake was the same per ABW, 2.0 +/- 0.2 and 2.0 +/- 0.1 g kg IBW(-1) x d(-1), NS, for the hypoenergetic and control formulas, respectively. Mean net nitrogen balance was not significantly different between the groups, even after patients were subgrouped by illness, nor was the percentage of patients achieving positive nitrogen balance. Duration of treatment averaged 10.5 +/- 2.6 d. Weight change did not differ significantly between groups. These data indicate that patients receiving hypoenergetic feedings providing 2 g protein x kg IBW(-1) x d(-1) achieved nitrogen balance comparable with patients given conventional total parenteral nutrition regimens, even when critically ill.
- 1 September 1993
- Vol. 177 (3) , 227-30
The significance of a positive test of morphine cholescintigraphy in hospitalized patients.
Morphine-augmented radionuclide cholescintigraphy (MC) is a useful adjunctive diagnostic tool for the identification of acute cholecystitis (AC) in patients who are hospitalized and critically ill with occult sepsis. The results of previous studies have demonstrated a reduction in false-positive rates, that is, nonvisualization, from 40 percent with standard radionuclide cholescintigraphy to 5 percent with MC in these high-risk patient groups, with an overall accuracy of 92 percent. This study was performed to determine the significance of a positive test result from MC in patients with occult sepsis. We reviewed the records of all 20 patients at high risk in whom MC was positive during the 35-month period ending 31 May 1992. AC was confirmed by laparotomy in all 16 patients who underwent surgical treatment. There were two patients who recovered with antibiotic therapy alone (considered false-positives) and two additional patients who died without operation or a confirmed diagnosis of AC (excluded from analysis). Thus, in this series, MC was associated with a positive predictive value of 0.89, confirming that it is a valuable adjunct in establishing the diagnosis of AC in patients who are seriously ill and hospitalized with occult sepsis.
- 1 September 1993
- Vol. 177 (3) , 227-30
The significance of a positive test of morphine cholescintigraphy in hospitalized patients.
Morphine-augmented radionuclide cholescintigraphy (MC) is a useful adjunctive diagnostic tool for the identification of acute cholecystitis (AC) in patients who are hospitalized and critically ill with occult sepsis. The results of previous studies have demonstrated a reduction in false-positive rates, that is, nonvisualization, from 40 percent with standard radionuclide cholescintigraphy to 5 percent with MC in these high-risk patient groups, with an overall accuracy of 92 percent. This study was performed to determine the significance of a positive test result from MC in patients with occult sepsis. We reviewed the records of all 20 patients at high risk in whom MC was positive during the 35-month period ending 31 May 1992. AC was confirmed by laparotomy in all 16 patients who underwent surgical treatment. There were two patients who recovered with antibiotic therapy alone (considered false-positives) and two additional patients who died without operation or a confirmed diagnosis of AC (excluded from analysis). Thus, in this series, MC was associated with a positive predictive value of 0.89, confirming that it is a valuable adjunct in establishing the diagnosis of AC in patients who are seriously ill and hospitalized with occult sepsis.
- 1 January 1993
- p. 19-43
Newer aspects of trauma care.